Metacrine, Inc. MTCR
0.58 USD 0.00 (+0.00%)
Jun 20, 2023, 3:11 PM EDT
0.58 Day range 0.5905
0.303 52-week range 0.5905
News
pennystocks.com Trading Penny Stocks Under $1: Strategies for Succes & 7 To Watch Penny stocks to buy under $1: A Beginner's Guide The post Trading Penny Stocks Under $1: Strategies for Succes & 7 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information |…
benzinga.com Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who…
benzinga.com Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with…
seekingalpha.com Metacrine: Potential Play On A Higher Bid Metacrine is getting acquired by Equillium in an all-stock transaction at an exchange ratio of 0.282x. Due to a decline in EQ share price since the announcement, the offer currently values MTCR at a…- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 413 companies reached new 52-week lows.
prnewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOTZ, ECOM, MTCR, MNRL NEW YORK , Oct. 6, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches…
benzinga.com Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday Gainers
prnewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, STOR, RCKT NEW YORK , Sept. 26, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
prnewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ECOM, SGFY, EQ, MTCR NEW YORK , Sept. 19, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 505 companies set new 52-week lows.
benzinga.com Metacrine To Slash Its Workforce By 50% Metacrine Inc (NASDAQ: MTCR) will ax half of its staff to conserve cash as it makes a last-stand drug development effort. Its shares are mired deep in penny stock territory after it floated its IPO…- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 400 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday Before 10 am on Friday, 110 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
zacks.com Is the Options Market Predicting a Spike in Metacrine (MTCR) Stock? Investors need to pay close attention to Metacrine (MTCR) stock based on the movements in the options market lately.
pennystocks.com 3 Penny Stocks To Watch After Jerome Powell's Fed Announcement 3 penny stocks to watch after Fed Chair Powells press conference. The post 3 Penny Stocks To Watch After Jerome Powell's Fed Announcement appeared first on Penny Stocks to Buy, Picks, News and…- benzinga.com 48 Biggest Movers From Friday Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday.
globenewswire.com Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With Nash SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and…
globenewswire.com Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021 SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and…
globenewswire.com Metacrine to Present at H.C. Wainwright 23rd Annual Global Investment Conference SAN DIEGO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and…
globenewswire.com Metacrine Updates MET642 Clinical Development Milestone and Reports Second-Quarter 2021 Results SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…
globenewswire.com Metacrine to Present at 2021 Canaccord Genuity Growth Conference SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…
benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 47 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 216 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During the morning session on Thursday, 152 stocks hit new 52-week lows.
globenewswire.com Metacrine to Present New Preclinical Data in Inflammatory Bowel Disease (IBD) at European Crohn's and Colitis Organisation (ECCO) 2021 Virtual Congress SAN DIEGO, July 06, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…
benzinga.com 26 Stocks Moving in Wednesday's Pre-Market Session Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss.
globenewswire.com Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021 SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…
globenewswire.com Metacrine Achieves Full Enrollment for MET409 Phase 2a Combination Trial in Patients With Type 2 Diabetes and NASH SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…
globenewswire.com Metacrine to Present at 2021 Jefferies Healthcare Conference SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…- benzinga.com Mid-Afternoon Market Update: Dow Rises 150 Points; VF Corp Shares Fall On Downbeat Earnings Toward the end of trading Friday, the Dow traded up 0.44% to 34,234 while the NASDAQ fell 0.26% to 13,500.91. The S&P also rose, gaining 0.07% to 4,161.93.
globenewswire.com Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting Preclinical data demonstrate synergistic effects between FXR agonist and JAK inhibitor, suggesting the potential for a change in the treatment paradigm for IBD Preclinical data demonstrate…
globenewswire.com Metacrine Achieves Enrollment Target for MET642 Phase 2a Trial Interim Analysis SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…
globenewswire.com Metacrine to Present at 2021 RBC Global Healthcare Conference SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal…- benzinga.com Stocks That Hit 52-Week Lows On Thursday During the morning session on Thursday, 67 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's morning session saw 33 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Friday Before 10 a.m. ET Friday, 62 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Before 10 a.m. ET Tuesday, 6 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's morning session saw 7 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's morning session, 92 stocks hit new 52-week lows.